Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 13Terminated 10Recruiting 7Unknown 4Active not recruiting 4Not yet recruiting 3Withdrawn 2Suspended 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Breast 1

Conditions

Stomach Neoplasms 2Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × taxane × Clear all
NCT02441933 2024-06-04

Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

Yonsei University

Phase 3 Unknown
878 enrolled
Breast

Breast Neoplasms

NCT04915807 2021-06-07

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Hallym University Medical Center

Unknown
222 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02624531 2021-01-07

SYSUGO-005

Sun Yat-sen University

Phase NA Unknown
60 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03668418 2018-09-12

xenoZ

University of Pisa

Unknown
120 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡